Abstract:HepatoBiliary Surg Nutr 2021 | https://dx.doi.org/10.21037/hbsn-21-365 Colorectal liver metastases (CRLM) are one of the most frequent clinical conditions. Over the last 20 years, the clinical outcome for patients with CRLM has improved greatly. Liver resection is the gold standard treatment for resectable CRLM, achieving a 5-year overall survival (OS) rate of 42% (1). However, the majority of patients with CRLM are not candidates for resection. With the development of thermal ablation, this technique provides an alternative treatment modality by either ablation alone or combined with resection. A recent review by Takahashi et al. summarized the current role of thermal ablation in the management of CRLM (2). In this review, the authors stated that ablation should not be used in lieu of liver resection for resectable CRLM based on current available evidence. Regarding the rapid advancement of systemic and local therapy, the treatment strategies for patients with CRLM are suggested to be discussed by the multidisciplinary team (MDT). Also, the authors listed the indications of ablation in their center, including unresectable liver lesions (tumor number ≤8, tumor size ≤4 cm), combined with hepatectomy, and resectable liver lesions but patients unfit to receive resection because of comorbidities and patient preference. These indications are highly feasible and can be referred by readers. It is noteworthy that the preferred tumor size and number were inconsistent in the light of the clinician’s experience. In general, thermal ablation is recommended for tumor size ≤3 cm. For tumor size between 3 and 5 cm, welllocated tumors can also be effectively treated depending on anatomical position and the treatment protocol used (3). Tumor number varies from 5 to 9 in the literature, which depends on the total liver tumor volume. The authors then pointed out the pros and cons of 3 approaches to perform ablation. Open and laparoscopy approaches allow better staging for occult liver metastases or peritoneal disease and protect surrounding organs from thermal injuries. It has been reported that additional metastases were detected in 10–25% of patients with CRLM by intraoperative ultrasound (4), which may result in changing the surgical strategy. The percutaneous approach provides the least invasive approach and has a significant role in patients with limited recurrent liver metastases after resection or ablation. Moreover, percutaneous ablation can be used as the ‘test-of-time’ approach reported by Livraghi et al. (5). The rationale of this approach is: (I) high technical success rate of ablation for small tumors without the need for resection; (II) if ablation was unsuccessful, the resection was still feasible; (III) if patients develop additional lesions after ablation and would no longer be suitable for resection, they can be spared unnecessary surgery. Among the 88 patients treated in the study by Livraghi et al. (5), 26% remained free of disease without the need for resection, 24% underwent resection after ablation, and 50% were unfit for resection due to disease progression. Compared with liver resection, local tumor recurrence (LTR) is a major issue after ablation. Predictors of LTR include tumor size ≥3 cm and ablation margin ≤0.5 cm. In Editorial

Anatomical thermal ablation as an alternative to surgical resection for subcapsular hepatocellular carcinoma

Clinical study of anatomical liver resection for hepatocellular carcinoma

Thermal ablation for hepatic tumors in high-risk locations

Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study

A New Local Ablation for Unresectable Primary Liver Tumor: Effect of Electrothermal and Electrochemical Therapy on Rat Liver

A Double Blinded Prospective Randomized Trial Comparing the Effect of Anatomic Versus Non-Anatomic Resection on Hepatocellular Carcinoma Recurrence

Anatomical ablation for small hepatocellular carcinomas using multiple applicators: a preliminary study

Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma

Thermal Ablation of Hepatic Hemangioma: A Multi-Center Experience with Long-Term Outcomes

Laparoscopic vs. open anatomical hepatectomy for intrahepatic cholangiocarcinoma: A retrospective cohort study

Thermal ablation with and without adjuvant systemic therapy: a nationwide multicenter observational cohort study of solitary colorectal liver metastases

Effects of general anesthesia versus local anesthesia in primary hepatocellular carcinoma patients presenting for thermal ablation surgery: a multiple center retrospective cohort study with propensity score matching

[Comparison of Clinical Efficacy of Thermal Ablation vs. Surgical Resection of Metachronous Colorectal Liver Metastasis]

Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns

Thermal ablation versus liver resection for hepatocellular carcinoma in patients with cirrhosis: a systematic review and meta-analysis of propensity-score matched studies

Standardization of Thermal Ablation in Treatment of Liver Tumor

Primary Experience of The Anatomical Liver Resection Procedure for Hepatocellular Carcinoma

Thermal Ablation Versus Hepatic Resection for Colorectal Cancer with Synchronous Liver Metastases: a Propensity Score Matching Study.

Network Meta-analysis on the Efficacy and Safety of Surgical Resection and Thermal Ablations for Hepatocellular Carcinoma in China

Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery

The Current Application of Thermal Ablation in Colorectal Liver Metastasis.